January 22, 2018
BMS says Opdivo and Yervoy benefitial for patients with certain metastatic colorectal cancer
Bristol-Myers Squibb Company today said that new data from a cohort of the phase 2 CheckMate -142 test of the…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: cancer
January 19, 2018
Bavarian Nordic kicks-off cancer candidate trial
Bavarian Nordic said Friday that it has kicked off a clinical trial of BN-Brachyury, a novel cancer immunotherapy candidate designed…
January 17, 2018
Ipsen, Exelixis promising with their treatment for patients with advanced liver cancer
Ipsen and Exelixis on Tuesday said that their phase 3 study of study of cabozantinib in patients with advanced liver…
January 16, 2018
FDA broadens Boehringer Ingelheim’s afatinib indication to previously untreated, metastatic NSCLC
Boehringer Ingelheim Pharmaceuticals has gotten an approval from the FDA, for a broadened indication of its afatinib for patients with…
January 4, 2018
Japan approves Merck’s Keytruda to treat patients with a type of bladder cancer
Merck’s anti PD-1 therapy Keytruda has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) to treat…
January 3, 2018
Second breakthrough therapy mark for Novartis’s Kisqali
Novartis on Wednesday sadi that Kisqali has gotten US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based…
December 12, 2017
Lilly strengthens its oncology department with a new name
Eli Lilly said on Monday that Kimberly Blackwell, M.D., one of the USA’s leading breast cancer researchers, will join Lilly Oncology as…
December 12, 2017
Juno, Calgene announce more potential of CAR T therapy
Juno Therapeutics, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, and Celgene Corporation have additional data from the…
December 5, 2017
Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells
Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a…
November 15, 2017
FDA OK’s AstraZeneca’s breast cancer drug
US Food and Drug Administration (FDA) has approved a new indication for AstraZeneca’s Faslodex(fulvestrant), expanding the indication to include use with…